Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry

BACKGROUND: Triptans are effective for many migraine patients, but some do not experience adequate efficacy and tolerability. The European Headache Federation (EHF) has proposed that patients with lack of efficacy and/or tolerability of ≥ 2 triptans (‘triptan resistance’) could be considered eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruscheweyh, Ruth, Gossrau, Gudrun, Dresler, Thomas, Freilinger, Tobias, Förderreuther, Stefanie, Gaul, Charly, Kraya, Torsten, Neeb, Lars, Ruschil, Victoria, Straube, Andreas, Scheidt, Jörg, Jürgens, Tim Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563311/
https://www.ncbi.nlm.nih.gov/pubmed/37817093
http://dx.doi.org/10.1186/s10194-023-01676-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563311/
https://www.ncbi.nlm.nih.gov/pubmed/37817093
http://dx.doi.org/10.1186/s10194-023-01676-0

Ejemplares similares